Shockwave Medical is a company that focuses on developing cardiovascular medical devices utilizing intravascular lithotripsy technology. This technology aims to treat vascular calcification through a unique mechanism of action, self-described as effective for modifying calcium in cardiovascular procedures.

Shockwave Medical

ShockWave Medical, Inc.

ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

Shockwave Medical | 91,211 followers on LinkedIn. Making waves for underserved patients with cardiovascular disease via novel technologies. ⚡🌊  | Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotripsy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. 

IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed.

Marketing at Shockwave Medical, Inc.

Lori Dossola Lyle

Erika Johnson

Senior Director, Data Platform and Business Intelligence

Bharath Natarajan

Medical Device Executive | General Management | Commercial Execution | Marketing | Professional Education | Business Development | Digital Surgery

Jason Shields

Making waves makes a difference. Shockwave #CoronaryIVL has become the leading solution for treating calcified CAD by delivering proven performance. Learn more about our validated, real-world impact on patients like yours: https://lnkd.in/dxdt5x6 US Rx only. Important Safety Information: http://bit.ly/3iEq7fC

Yesterday we celebrated our International Quality Day with presentations from Manufacturing and Operations leadership, booth activities — and of course, great food. A huge thanks goes out to our #ShockNation Quality Teams for your commitment to delivering innovative, safe and effective products. #JNJMedTechProud #ShockOn

Congratulations to Drs. Timothy D. Henry and Steven G. Rudick for successfully randomizing the 100th COSIRA II patient at Christ Hospital in Cincinnati, OH yesterday! Thank you to all the participating sites on this momentous occasion for advancing the treatment of patients suffering from Refractory Angina. On to the next wave of patients! To learn more about the #COSIRAII trial and for a list of participating sites visit www.clinicaltrials.gov ISI http://bit.ly/3iEq7fC Caution: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada. Please contact your local representative for specific country availability.

For International Physicians: The #ShockwaveReducer team is not slowing down in the second half of the year! See the milestones and achievements including the REDUCER-I 12-month results from ESC Congress, the Reducer Symposium at #EuroPCR , and the recent publications. Read the Reducer Review today: https://lnkd.in/g4edZ3T3 Learn more about the #ShockwaveReducer : https://lnkd.in/g7-UqNsF ISI http://bit.ly/3iEq7fC Caution: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada. Please contact your local representative for specific country availability.

Got a New York minute? 🗽 Join us November 20, 12-1pm for our debate-style #ShockwaveIVL lunch symposium at #VEITH2024 . Hear from Drs Sahil Parikh, Misty Humphries, Stefano Fazzini, Frank Arko, Michel Bosiers, Mazin Foteh & Liz Genovese as they share optimal methods for treating vascular calcium. Add to Calendar: https://lnkd.in/gvb9NjFP VEITHsymposium US Rx only. Important Safety Information: http://bit.ly/3iEq7fC

Is it time to rethink your treatment strategy in calcified iliac arteries? Read the latest Vascular News supplement to learn how #ShockwaveL6 is changing the paradigm for management of severe iliac calcification. US Rx only. ISI http://bit.ly/3iEq7fC https://lnkd.in/e_jK3bpC

Last week we had the pleasure to attend #CSC2024 and hear our valued physicians share best practices and latest data about #ShockwaveIVL . Kudos to Dr Ander Regueiro and the team from Hospital Clínic de Barcelona for performing an educational LIVE case, and to Dr Guillermo Galeote García and the team from Hospital Universitario La Paz for presenting an engaging Case in a Box. Thank you to Dr Nieves Gonzalo for her insightful interview about the #EMPOWERCAD study, which has recently completed enrollment. US Rx only. Important Safety Information: http://bit.ly/3iEq7fC

What devices does Dr Rhian Davies choose when treating coronary calcium? Hear her advice in this short peer-to-peer video. US Rx only. Important Safety Information: http://bit.ly/3iEq7fC #ShockwaveP2P #ShockwaveIVL

Shockwave #CoronaryIVL isn't the same old drill — it's a safe & sound calcium strategy for helping patients like yours. Learn more about our expert-validated, real-world impact: https://lnkd.in/dxdt5x6 US Rx only. Important Safety Information: http://bit.ly/3iEq7fC #ShockwaveIVL

81M with CAD, type 2 diabetes, and recent right foot amputation for #CLTI presented with 4 weeks of rest pain of left foot and toe discoloration. Dr. Juyong Lee at UConn Health John Dempsey Hospital treated the CTO of the SFA with #ShockwaveE8 . After wiring, Shockwave E8 crossed without predilatation and 400 pulses were delivered, followed by placement of a DES. Brisk post-procedure in-line flow to the foot was restored without complications, and rest pain resolved immediately. Dr. Lee shared, “The Shockwave E8 catheter gave great luminal gain in a calcified CTO, the post-IVL angiogram after using Shockwave looked fantastic with no dissections. I was impressed with the ability of the device to cross into a CTO with no pre-dilation first.” Congratulations, also, on performing the first Shockwave E8 case in the state of Connecticut! US Rx only. Important Safety Information: http://bit.ly/3iEq7fC #ShockwaveIVL

COM:SHOCKWAVEMEDICAL

Shockwave Medical

Last Close

334.83

30/05 20:00

Market Cap

12.57B

Beta: -

Volume Today

3.95M

Avg: -

name

homepage url

country

linkedin url

employee count

sector

industry

revenue

monthly webtraffic

monthly webtraffic growth

stage

raised capital

Description

peer of

competitor of

Metrics